HK Stock Market Move | MICROPORT(00853) rose nearly 5% in anticipation of the merger between MicroPort MedBot and CRM Cayman, which is expected to be completed around tomorrow.
Microport Medical (00853) rose nearly 5%, as of the time of publication, it rose 4.64% to 10.61 Hong Kong dollars, with a turnover of 67.2256 million Hong Kong dollars.
MICROPORT (00853) rose nearly 5%, as of the time of writing, it rose 4.64%, to HK $10.61, with a turnover of HK $67.2256 million.
On the news front, MICROPORT announced that the independent shareholders of MicroPort had approved the merger agreement and the transactions proposed thereunder at the special general meeting of shareholders held on December 15, 2025. The merger is expected to be completed around December 19, 2025, at which point all existing issued shares of CRM Cayman (including common shares and preferred shares) will be cancelled in exchange for common shares of MicroPort, and CRM Cayman will become a wholly-owned subsidiary of MicroPort.
The announcement stated that this strategic merger is a key measure for optimizing resource allocation and enhancing overall competitiveness, aiming to strengthen synergies in the field of structural heart disease and arrhythmia management. By integrating complementary product lines and global channel resources, the company will accelerate market penetration and improve operational efficiency; leveraging mature overseas teams and infrastructure to further optimize local service capabilities and supply chain resilience.
Related Articles

China Feihe (06186) spent HK$12.3269 million on December 18 to repurchase 304,600 shares.

New stock news | With a compound annual growth rate of 2500%, Bitar Technology aims to become the "first stock for Hong Kong GPU" with over 1.2 billion orders in hand.

Shanghai Fosun Pharmaceutical (600196.SH) Signs Cooperation and Option Agreement with Clavis Bio.
China Feihe (06186) spent HK$12.3269 million on December 18 to repurchase 304,600 shares.

New stock news | With a compound annual growth rate of 2500%, Bitar Technology aims to become the "first stock for Hong Kong GPU" with over 1.2 billion orders in hand.

Shanghai Fosun Pharmaceutical (600196.SH) Signs Cooperation and Option Agreement with Clavis Bio.






